Sometimes it is injected in other acupuncture points depending on your specific situation
Clinical guidance consistently identifies dietary fiber and adequate hydration as primary first-line strategies for managing constipation in GLP-1 users
Clinical data shows semaglutide users report nausea in roughly 2530% of cases, while tirzepatide users experience nausea in 3040% of early treatment phases
Studies are also underway to assess the efficacy of GLP1s for: Addiction: Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity (Scientific Reports, Nature), Semaglutide for Alcohol Use Disorder (Phase II clinical trial by UNC) Alzheimer's: The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease (Frontiers in Endocrinology) Mental Health & Suicidal Ideation: Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Depression Diagnoses (Epic Research) Alcohol-related liver disease ( Novo Nordisk clinical trial ) Osteoarthritis ( STEP 9 ) Metabolic dysfunction-associated steatohepatitis (MASH): Tirzepatide for Metabolic DysfunctionAssociated Steatohepatitis with Liver Fibrosis This is just the beginning
Interestingly, while non-fatal events did not significantly differ, oral semaglutide clearly reduced deaths from any cause (HR: 0.51, CI: 0.31 to 0.84) or cardiovascular causes (HR: 0.49, CI: 0.27 to 0.92)
First, start by eliminating all seed oils and highly processed foods - trying instead to stick to a majority of one ingredient foods
